TY - JOUR AU - Lolita, Lolita AU - Ikhsanudin, Azis PY - 2022/11/30 Y2 - 2024/03/29 TI - Illness Risk Perceptions and Efficacy Beliefs Among Indonesian in the Course of COVID-19 Pandemic JF - Borneo Journal of Pharmacy JA - Borneo J Pharm VL - 5 IS - 4 SE - Clinical-Community Pharmacy DO - 10.33084/bjop.v5i4.3287 UR - https://journal.umpr.ac.id/index.php/bjop/article/view/3287 SP - 396-405 AB - <p style="text-align: justify;">COVID-19, a worldwide pandemic, has posed a significant challenge to public health systems worldwide. Health risk perception and efficacy belief are primary constructs influencing individuals' protective behavior due to the outbreak. Our study investigated each item of illness risk perception, efficacy belief, and its related factors concerning the COVID-19 pandemic. An analytical cross-sectional study was conducted among 227 respondents aged 17 to 70. Data collection was conducted using convenience sampling by distributing the web questionnaire between April and July 2020. Mann-Whitney or Kruskal-Wallis bivariate analysis was performed using SPSS version 21.0 to assess the relationship between individual characteristic factors, illness risk perception, and efficacy belief. The study established that respondents had a medium to a high level of illness risk perception and a reasonable efficacy belief in dealing with the COVID-19 pandemic. Region (p=0.027) and occupation (p=0.036) differences were significantly associated with the threat and severity perception, respectively. Smoking history (p=0.037), supplement use (p=0.029), and occupation (p=0.018) differences were significantly associated with self-efficacy. Meanwhile, gender (p=0.045) differences were significantly associated with response efficacy. Therefore, the public's illness risk perception and efficacy belief could be substantial in planning, modifying, and implementing a coordinated response for risk communication in current and future epidemics.</p> ER -